Valeant Pharmaceuticals International Inc announces approval of Retin-A Micro Microsphere 0.08 pct


Friday, 31 Jan 2014 08:01am EST 

Valeant Pharmaceuticals International Inc:Says it has received approval from the Food and Drug Administration (FDA) for its Supplemental New Drug Application (sNDA) for Retin-A Micro (tretinoin) Gel microsphere 0.08 pct for the topical treatment of acne vulgaris. 

Company Quote

120.47
-0.21 -0.17%
4:01pm EDT